Creating a virtual laboratory to improve public health and clinical research.
Official title: Institute for Clinical and Translational Science
Funded at University of California-Irvine · NIH-10841196 · Data updated 2026-11-12
This study is working to create a virtual lab that helps improve treatments and care for rare diseases using new technology and teamwork with the community, so patients can look forward to better options and healthier lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project start | July 16, 2024 |
| Project end | June 30, 2031 |
| Funding year | 2024 |
| Award (this year) | $4,099,887 |
| NIH project number | 1UM1TR004927-01 |
| Project ID | NIH-10841196 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals affected by rare diseases or those from diverse communities facing health inequities.
✕Less likely to help
Patients with common conditions that are not the focus of this research may not receive direct benefits.
What this research studies
This research aims to establish the UCI CTSA Hub as a dynamic virtual laboratory that enhances translational science. It focuses on transforming clinical trials for rare diseases, developing innovative diagnostic and therapeutic technologies, and improving neurorehabilitation practices using AI and robotics. The project emphasizes collaboration with community stakeholders to address health disparities and improve public health outcomes. Patients may benefit from new treatment options and improved healthcare practices resulting from this initiative.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking advancements in treatment options and healthcare practices that reduce health disparities.
How similar studies have gone: Previous research initiatives have shown success in similar collaborative approaches to translational science and addressing health disparities.
Where this research is happening
-
University of California-Irvine
Irvine, United States Active
Researchers
- Principal investigator: Vilain, Eric J. — University of California-Irvine
- Study coordinator: Vilain, Eric J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.